Mylan Romania Sold RON160M Worth Of Drugs In 2016

01.19.2017 By Ecaterina Craciun

Mylan Romania, the local division of U.S. pharmaceutical company Mylan, one of the world’s largest drugmakers, posted sales of RON160 million in 2016, reaching a market share of 1.6% two years after its entry on the Romanian market, according to studies by market research company Cegedim, as cited by Adrian Grecu, country manager Mylan Romania.



To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
Mylan Romania
, drugs
, sales